areas through its network of research-enabled Visit Centres. Every
study is assessed individually to determine the most appropriate delivery
model, infrastructure and participant pathway.
Therapeutic Areas
Orizzonte supports clinical research across a range of therapeutic areas through its network of research-enabled Visit Centres.
Every study is assessed individually to determine the most appropriate delivery model, infrastructure and participant pathway.
Supporting Research Across Diverse Therapeutic Areas
Clinical research plays a vital role in advancing understanding of diseases, treatments, diagnostics, and healthcare interventions.
Different therapeutic areas require different delivery approaches, participant pathways, and levels of clinical support.
Orizzonte’s infrastructure model is designed to support research delivery across a broad range of therapeutic areas where study requirements align with Visit Centre capability and operational feasibility.
Our Therapeutic Areas
Our research network supports studies across a broad range of therapeutic areas, depending on study requirements and operational feasibility.
Research into respiratory conditions, prevention and emerging treatments.
Studies focused on heart health, cardiovascular disease and prevention.
Research into diabetes, obesity and metabolic disorders.
Studies evaluating vaccines and infectious disease prevention.
Research supporting women’s health across all stages of life.
Studies involving healthy volunteers to support the development of future healthcare interventions.
Selecting the Right Delivery Model
Every study is different. Before delivery begins, we assess:
▪️ Protocol requirements
▪️ Participant populations
▪️ Clinical procedures
▪️ Infrastructure capability
▪️ Operational feasibility
Every study is different. Before delivery begins, we assess:
Selecting the Right Delivery Model
Every study is different. Before delivery begins, we assess:
▪️ Protocol requirements
▪️ Participant populations
▪️ Clinical procedures
▪️ Infrastructure capability
▪️ Operational feasibility
Every study is different. Before delivery begins, we assess:
Empowering clinicians to become research-active is not just about advancing science — it’s about transforming care at its core
Dr. Aries Maximus Ogbuokiri
COO
Empowering clinicians to become research-active is not just about advancing science — it’s about transforming care at its core
Dr. Aries Maximus Ogbuokiri
COO
Supporting Diverse Research
Some studies are well suited to Visit Centres, while others require hospitals or specialist services.
Our approach allows the delivery model to be matched to the requirements of each study, rather than applying a one-size-fits-all approach.
Supporting Diverse Research
Some studies are well suited to Visit Centres, while others require hospitals or specialist services.
Our approach allows the delivery model to be matched to the requirements of each study, rather than applying a one-size-fits-all approach.
Who we work with
Pharmaceuticals
Hospitals
Academia
Real-World Patient Population
Inclusive Recruitment
Fit-for-Purpose Sites
Why Our Model Works
Real-World Patient Population
Inclusive Recruitment
Fit-for-Purpose Sites
Frequently Asked Questions
We support research across a range of therapeutic areas, subject to study requirements and operational feasibility.
No. Every study is assessed individually to determine the most appropriate delivery model.
We review protocol requirements, participant populations, infrastructure capability and operational feasibility before selecting the most appropriate delivery model.
Yes. We work with Sponsors and CROs to support commercial clinical research through our research infrastructure.
Frequently Asked Questions
Research may be supported across a range of therapeutic areas depending on study requirements, infrastructure capability, and operational feasibility.
No. Suitability depends on study complexity, participant safety considerations, required procedures, and infrastructure requirements.
Studies are evaluated through feasibility assessment, operational planning, and infrastructure review before delivery pathways are determined.
Yes. Orizzonte works with Sponsors and CROs to support commercial clinical research delivery through its infrastructure model.
Research capabilities continue to evolve as the network develops and new delivery opportunities emerge.
Our Network of Partners
Who we work with
Biotechs
Pharmaceutical Industry
CROs
NHS
Discuss Your Study
Talk to our team about delivering your next study through Orizzonte’s network of research-enabled Visit Centres.